Is minimal change esophagitis really part of the spectrum of endoscopic findings of gastroesophageal reflux disease? A prospective, multicenter study

Background and study aims: Although minimal changes are one of the endoscopic findings of nonerosive reflux disease (NERD), the clinical significance of minimal changes is controversial. This study evaluated the clinical significance of minimal changes and examined whether such changes have diagnostic value in gastroesophageal reflux disease (GERD).

Patients and methods: The endoscopic findings were assessed from 1445 patients identified as having minimal changes who were seen across 30 institutions between April and September 2009. Six endoscopic criteria reported to have acceptable-to-good agreement between endoscopists were used for assessing minimal changes: erythema, blurring of the Z-line, friability, decreased vascularity, white turbid discoloration, and edema or accentuation of the mucosal folds. The diagnosis of GERD was based on the GerdQ, a questionnaire for identifying GERD among patients with upper gastrointestinal symptoms.

Results: Of the 1445 patients, 44.5 % were categorized into the GERD group based on the GerdQ. No significant differences in clinical characteristics were found between the GERD and non-GERD groups, except in age and height. Blurring of the Z-line and erythema were the most common endoscopic findings of minimal changes in this study. Only one of the six findings (16.7 %) was more common in the GERD group than in the non-GERD group. Using more than one endoscopic finding was not more useful for identifying GERD than using only one endoscopic finding.

Conclusions: Most of the endoscopic findings indicating minimal changes are not associated with GERD. The clinical significance of minimal changes should be reconsidered.

References

• 1 Dent J, Armstrong D, Delaney B et al. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs.  Gut. 2004;  53 (Suppl. 4) iv1-iv24
• 2 Moayyedi P, Talley N J. Gastro-oesophageal reflux disease.  Lancet. 2006;  367 2086-2100
• 3 Kahrilas P J. Diagnosis of symptomatic gastroesophageal reflux disease.  Am J Gastroenterol. 2003;  98 S15-S23
• 4 Hongo M. Minimal changes in reflux esophagitis: red ones and white ones.  J Gastroenterol. 2006;  41 95-99
• 5 Lee J H, Kim N, Chung I K et al. Clinical significance of minimal change lesions of the esophagus in a healthy Korean population: a nationwide multi-center prospective study.  J Gastroenterol Hepatol. 2008;  23 1153-1157
• 6 Nakamura T, Shirakawa K, Masuyama H et al. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis.  Aliment Pharmacol Ther. 2005;  21 19-26
• 7 Kiesslich R, Kanzler S, Vieth M et al. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy.  Dig Dis. 2004;  22 221-227
• 8 Shimizu Y, Dobashi K, Kobayashi S et al. High prevalence of gastroesophageal reflux disease with minimal mucosal change in asthmatic patients.  Tohoku J Exp Med. 2006;  209 329-336
• 9 Kusano M, Ino K, Yamada T et al. Interobserver and intraobserver variation in endoscopic assessment of GERD using the “Los Angeles” classification.  Gastrointest Endosc. 1999;  49 700-704
• 10 Armstrong D, Bennett J R, Blum A L et al. The endoscopic assessment of esophagitis: a progress report on observer agreement.  Gastroenterology. 1996;  111 85-92
• 11 Jones R, Junghard O, Dent J et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care.  Aliment Pharmacol Ther. 2009;  30 1030-1038
• 12 Shaw M, Dent J, Beebe T et al. The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials.  Health Qual Life Outcomes. 2008;  6 31
• 13 Revicki D A, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease.  Qual Life Res. 1998;  7 75-83
• 14 Hong S P, Park P W, Hwang S G et al. Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder.  Korean J Intern Med. 2004;  19 93-98
• 15 Ohara S, Kouzu T, Kawano T, Kusano M. Nationwide epidemiological survey regarding heartburn and reflux esophagitis [in Japanese].  Nippon Shokakibyo Gakkai Zasshi. 2005;  102 1010-1024
• 16 Kahrilas P J, Shaheen N J, Vaezi M F. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.  Gastroenterology. 2008;  135 1392-1413, 1413.e1 – e5
• 17 Fock K M, Talley N J, Fass R et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update.  J Gastroenterol Hepatol. 2008;  23 8-22
• 18 Dean B B, Gano A D Jr., Knight K et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease.  Clin Gastroenterol Hepatol. 2004;  2 656-664
• 19 Kusano M, Shirai N, Yamaguchi K et al. It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole – a report from a study with Japanese patients.  Dig Dis Sci. 2008;  53 3082-3094